VTR

Ventas
D

VTR

Arincen48/100B

Ventas financials

Yes. Ventas earned 265.60M USD of net income over the last twelve months, 3.9% of its revenue. It made a profit in 27 of its 31 fiscal years since 1995. Its last loss was in fiscal year 2023.

Revenue (TTM)
6.78B USD
Net income (TTM)
265.60M USD
Cash and short-term investments
202.01M USD
Total debt
12.67B USD
Shareholders' equity
15.81B USD

Cash, debt and equity as of 30 Sept 2026.

Ventas earnings

Next earnings · Q4 FY2026
EPS estimate
0.15 USD
Revenue estimate
1.83B USD
Last quarter · Q3 FY2026
EPS0.13Missed -19.8%Revenue1.83BBeat +3.6%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q1 FY20270.17——+54.55%1.89B——+13.82%
Q4 FY20260.15——+1.33%1.83B——+16.62%
Q3 FY20260.160.13-19.80%-7.14%1.77B1.83B+3.57%+23.02%
Q2 FY20260.140.14-1.62%-6.67%1.68B1.73B+2.91%+21.73%
Q1 FY20260.120.11-10.50%0.00%1.59B1.66B+4.51%+22.01%
Q4 FY20250.100.15+48.96%+15.38%1.50B1.57B+4.09%+21.67%
Q3 FY20250.090.14+52.19%-82.50%1.44B1.49B+3.62%+20.44%
Q2 FY20250.850.15-82.35%+200.00%1.38B1.42B+3.07%+18.31%

Ventas growth and profitability

Full income statement
Revenue (TTM)
6.78B USD
Net income (TTM)
265.60M USD
Gross margin
-0.89%
Operating margin
12.17%
Net margin
3.91%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20255.83B+18.47%251.38M+209.76%-5.90%14.17%4.31%2.24B+22.97%
FY20244.92B+9.48%81.15M—42.59%13.83%1.65%1.82B+7.08%
FY20234.50B+8.93%-40.97M—43.06%9.24%-0.91%1.70B+13.37%
FY20224.13B+7.87%-47.45M-196.81%44.71%11.72%-1.15%1.50B+1.37%
FY20213.83B+0.86%49.01M-88.84%45.44%11.01%1.28%1.48B-16.42%

Ventas revenue breakdown

By product

FY2025
Senior Living Operations: 74.0%Outpatient Medical And Research Portfolio: 15.5%Triple Net Leased Properties: 10.4%74.0%Senior Living Operations15.5%Outpatient Medical And Research Portfolio10.4%Triple Net Leased Properties
SegmentRevenueShare of revenueChange on the year
Senior Living Operations4.28B74.0%+26.8%
Outpatient Medical And Research Portfolio897.90M15.5%—
Triple Net Leased Properties601.58M10.4%-3.3%

By region

FY2025
United States: 89.3%Canada: 9.5%United Kingdom: 1.2%89.3%United States9.5%Canada1.2%United Kingdom
RegionRevenueShare of revenueChange on the year
United States5.21B89.3%+19.3%
Canada552.92M9.5%+5.0%
United Kingdom71.23M1.2%+131.7%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20251.65B1.28B
FY20241.33B1.05B
FY20231.12B860.46M
FY20221.12B898.03M
FY20211.03B840.84M
FY20201.45B1.30B
FY20191.44B1.28B
FY20181.44B1.31B
FY20171.43B1.30B
FY20161.37B1.25B

Ventas financial health

Full balance sheet
Cash and short-term investments
202.01M USD
Total debt
12.67B USD
Net cash
-12.47B USD
Current ratio
0.44
Debt to equity
0.80
Piotroski score
6 / 9
Altman Z-score
1.92

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY2025741.07M13.22B1.28B
FY2024897.85M13.74B1.05B
FY2023508.79M13.69B860.46M
FY2022122.56M12.49B898.03M
FY2021149.73M12.22B840.84M

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202527.59B15.01B12.53B
FY202426.19B15.36B10.77B
FY202324.73B15.18B9.49B
FY202224.16B13.94B10.15B
FY202124.72B13.77B10.85B
FY202023.93B13.65B10.18B
FY201924.69B14.15B10.45B
FY201822.58B12.31B10.22B
FY201723.95B13.02B10.87B
FY201623.17B12.64B10.46B

Ventas valuation

Price to earnings ratio (TTM)
165.70
Forward P/E (FY2026)
159.07
Price to sales (TTM)
6.97
Price to book
2.99
EV / EBITDA (TTM)
23.12

Capital structure

Market capitalization
47.32B USD
+
Total debt
12.67B USD
−
Cash and short-term investments
202.01M USD
=
Enterprise value
59.78B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)77.27————
FY2027 (est.)104.0977.27———
FY2026 (est.)159.07104.09———
Now (TTM)165.70109.046.972.9923.12
FY2025140.69137.526.042.8121.30
FY2024294.45121.504.922.2520.37
FY2023-498.40493.994.452.1119.53
FY2022-346.54340.134.071.6619.46
FY2021393.23340.135.111.8021.39

Ventas against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Omega Healthcare Investors, Healthpeak Properties, Welltower, American Healthcare REIT, CareTrust REIT, and Healthcare Realty Trust, the US REIT - Healthcare Facilities companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • Gross marginLowest in 5 years-5.9%
    -5.9%45.4%
    Against its peers: 6 of 7Peers' median 30.8%
  • Operating marginHighest in 5 years14.2%
    9.2%14.2%
    Against its peers: 4 of 7Peers' median 13.7%
  • Net marginHighest in 5 years4.3%
    -1.1%4.3%
    Against its peers: 4 of 7Peers' median 5.9%
  • Return on equityHighest in 5 years2.0%
    -0.5%2.0%
    Against its peers: 5 of 7Peers' median 2.2%
  • Free cash flow marginHighest in 5 years22.0%
    19.1%22.0%
    Against its peers: 5 of 7Peers' median 35.5%
  • Revenue growthHighest in 5 years18.5%
    0.9%18.5%
    Against its peers: 3 of 7Peers' median 11.6%
  • EPS growthHighest in 5 years184.2%
    -200.0%184.2%
    Against its peers: 1 of 5Peers' median 6.8%
  • Debt to EBITDALowest in 5 years5.90×
    5.90×8.33×
    Against its peers: 4 of 7Peers' median 5.98×
  • Current ratioAbove its median0.96
    0.611.04
    Against its peers: 6 of 7Peers' median 1.65

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Ventas dividends

Annual dividend
2.08 USD
Dividend yield (indicated)
2.32%
Payout ratio (FFO)
53.28%
Years of dividend growth
2
Frequency
Quarterly
Last payment
0.52 USD
Last ex-dividend date
30 Sept 2026
Last payment date
15 Oct 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share1.891.801.801.801.802.493.173.162.332.97

Ventas ownership

Institutions
111.05%
Institutional holders
980 (+24)
Free float
99.46%

Who owns the shares

Institutions 100.0% Others 0.0%
As of 30 Jun 2026

Shares free to trade

Free float 525.97M shares ·99.5% Closely held 2.85M shares ·0.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 2026007.39K0.00
Q3 20260017.77K0.00
Q2 20261127.84K7.37K
Q1 202605473.96K342.73K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025455.08M462.62M+11.11%
FY2024411.77M416.37M+2.64%
FY2023401.81M405.67M+8.65%
FY2022373.37M373.37M-3.35%
FY2021382.79M386.30M+2.60%

Common questions about Ventas's financials

Source: Financial Modeling Prep